Osmotic Diuretic [EPC]

Osmotic Diuretic [EPC] was reported 5225 times

Drugs of the Osmotic Diuretic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PARASITIC ENCEPHALITIS 4 0.4444
1 SLEEP DISORDER THERAPY 87 0.4394
2 ANTACID THERAPY 51 0.3923
3 APPENDICOLITH 142 0.3669
4 ANALGESIC THERAPY 90 0.2804
5 DRUG THERAPY 88 0.2596
6 CONGENITAL HIATUS HERNIA 52 0.2281
7 MALIGNANT MELANOMA STAGE 0 44 0.2105
8 CSF VOLUME DECREASED 5 0.1923
9 ANTICOAGULANT THERAPY 52 0.1831
10 PROCALCITONIN DECREASED 12 0.1714
11 BALAMUTHIA INFECTION 4 0.1379
12 PULMONARY SEPTAL THICKENING 12 0.1348
13 TICK-BORNE VIRAL ENCEPHALITIS 8 0.1333
14 BACTEROIDES INFECTION 27 0.1034
15 HYPOTONY MACULOPATHY 4 0.0976
16 ACUTE HAEMORRHAGIC LEUKOENCEPHALITIS 3 0.0833
17 EOSINOPHIL PERCENTAGE DECREASED 12 0.0603
18 HYPERPHOSPHATAEMIA 122 0.0567
19 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 46 0.0496
20 BLOOD PHOSPHORUS INCREASED 132 0.0483
21 BLOOD CREATINE DECREASED 12 0.0397
22 SMALL BOWEL ANGIOEDEMA 4 0.0374
23 LEUKOSTASIS SYNDROME 4 0.0301
24 PROPOFOL INFUSION SYNDROME 20 0.0284
25 POSTOPERATIVE RENAL FAILURE 4 0.0276
26 TOXIC NEUROPATHY 10 0.0254
27 RED BLOOD CELLS URINE POSITIVE 24 0.0248
28 CLOSTRIDIAL SEPSIS 6 0.0248
29 HYPEROSMOLAR STATE 7 0.0243
30 SPINAL CORD INJURY CERVICAL 6 0.0238
31 INCISION SITE PAIN 28 0.0238
32 TOXIC OPTIC NEUROPATHY 10 0.0230
33 TUMOUR PERFORATION 7 0.0220
34 TOTAL LUNG CAPACITY DECREASED 35 0.0219
35 AORTIC VALVE CALCIFICATION 11 0.0214
36 ORGANIC BRAIN SYNDROME 4 0.0213
37 DECEREBRATE POSTURE 3 0.0204
38 BLOOD URIC ACID INCREASED 116 0.0201
39 C-REACTIVE PROTEIN DECREASED 13 0.0199
40 HYPOPHOSPHATAEMIA 143 0.0193
41 IRON DEFICIENCY 84 0.0187
42 ELECTROCARDIOGRAM T WAVE PEAKED 7 0.0174
43 MYASTHENIA GRAVIS 140 0.0173
44 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 86 0.0170
45 BLOOD FOLATE DECREASED 12 0.0165
46 PLEURITIC PAIN 45 0.0163
47 MULTI-ORGAN FAILURE 277 0.0160
48 FEAR 430 0.0160
49 BRAIN HERNIATION 46 0.0154
50 APPENDICITIS 142 0.0152
51 FEAR OF DEATH 34 0.0151
52 AORTIC STENOSIS 50 0.0143
53 VENTRICULAR FIBRILLATION 159 0.0143
54 HUMAN HERPESVIRUS 6 ENCEPHALITIS 4 0.0141
55 RESPIRATORY SYMPTOM 40 0.0140
56 ACID BASE BALANCE ABNORMAL 3 0.0134
57 ENTEROBACTER BACTERAEMIA 4 0.0132
58 RENAL INJURY 382 0.0128
59 MENINGITIS TUBERCULOUS 7 0.0125
60 UREAPLASMA INFECTION 5 0.0123
61 BLOOD OSMOLARITY INCREASED 4 0.0122
62 LUNG OPACITY 32 0.0121
63 ANHEDONIA 312 0.0119
64 CYTOMEGALOVIRUS GASTRITIS 3 0.0119
65 CARDIOGENIC SHOCK 163 0.0113
66 BLOOD UREA DECREASED 14 0.0113
67 CHOROIDAL EFFUSION 9 0.0112
68 CATHETER SITE THROMBOSIS 3 0.0109
69 BLOOD CHOLINESTERASE DECREASED 3 0.0109
70 FLOPPY IRIS SYNDROME 4 0.0108
71 NEUROSARCOIDOSIS 4 0.0106
72 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
73 ENGRAFTMENT SYNDROME 6 0.0102
74 PARVOVIRUS INFECTION 4 0.0099
75 TUMOUR ASSOCIATED FEVER 4 0.0098
76 LEFT ATRIAL DILATATION 12 0.0094
77 MYOGLOBINURIA 5 0.0094
78 COMPLICATIONS OF TRANSPLANTED KIDNEY 21 0.0093
79 TROPONIN INCREASED 70 0.0092
80 BENIGN PROSTATIC HYPERPLASIA 47 0.0091
81 BRAIN DEATH 28 0.0091
82 COAGULATION TIME SHORTENED 3 0.0090
83 BRAIN OEDEMA 112 0.0089
84 GASTROINTESTINAL BACTERIAL INFECTION 10 0.0087
85 PUPILS UNEQUAL 10 0.0087
86 BREATH SOUNDS ABNORMAL 43 0.0087
87 HAEMORRHAGIC CEREBRAL INFARCTION 6 0.0085
88 FANCONI SYNDROME 12 0.0085
89 INFECTION IN AN IMMUNOCOMPROMISED HOST 6 0.0084
90 CEREBRAL VENOUS SINUS THROMBOSIS 7 0.0083
91 OPTIC ATROPHY 13 0.0080
92 TOXIC SHOCK SYNDROME 5 0.0079
93 MACULOPATHY 28 0.0079
94 PARAPARESIS 14 0.0079
95 ABDOMINAL COMPARTMENT SYNDROME 5 0.0078
96 CEREBRAL ARTERY THROMBOSIS 4 0.0078
97 CEREBRAL TOXOPLASMOSIS 7 0.0075
98 MULTIPLE ORGAN DYSFUNCTION SYNDROME 207 0.0073
99 HAEMORRHAGIC TRANSFORMATION STROKE 11 0.0073
100 BLOOD CALCIUM INCREASED 64 0.0073
101 LISTERIOSIS 8 0.0072
102 CANDIDA TEST POSITIVE 3 0.0072
103 BACTERIAL INFECTION 134 0.0072
104 INJURY 495 0.0070
105 DELAYED GRAFT FUNCTION 5 0.0070
106 LYMPHOCYTE MORPHOLOGY ABNORMAL 4 0.0069
107 OPTIC NERVE DISORDER 11 0.0069
108 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 117 0.0068
109 PARESIS 15 0.0067
110 BLOOD CHLORIDE DECREASED 17 0.0066
111 SUPERIOR SAGITTAL SINUS THROMBOSIS 5 0.0063
112 UNEVALUABLE EVENT 472 0.0062
113 INCISION SITE HAEMORRHAGE 5 0.0062
114 CHEMICAL BURN 7 0.0061
115 CEREBRAL VENOUS THROMBOSIS 11 0.0061
116 HYPERLIPIDAEMIA 70 0.0059
117 EMBOLISM ARTERIAL 7 0.0058
118 PROTEIN URINE PRESENT 29 0.0058
119 BRAIN MIDLINE SHIFT 3 0.0057
120 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
121 HYPERLEUKOCYTOSIS 5 0.0056
122 NEUROLOGICAL DECOMPENSATION 13 0.0056
123 INTRACRANIAL VENOUS SINUS THROMBOSIS 6 0.0056
124 PROTEIN TOTAL DECREASED 21 0.0056
125 INTRACRANIAL PRESSURE INCREASED 31 0.0056
126 NEURALGIA 134 0.0055
127 ANGLE CLOSURE GLAUCOMA 14 0.0055
128 ASCITES 161 0.0055
129 EOSINOPHIL COUNT DECREASED 13 0.0055
130 HYPERNATRAEMIA 27 0.0054
131 CHOROIDAL DETACHMENT 3 0.0054
132 HYPERCHOLESTEROLAEMIA 52 0.0054
133 KLEBSIELLA SEPSIS 6 0.0053
134 KLEBSIELLA BACTERAEMIA 5 0.0053
135 CREATINE KINASE INCREASED 4 0.0052
136 BLOOD FIBRINOGEN INCREASED 4 0.0051
137 CRYSTAL NEPHROPATHY 3 0.0051
138 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
139 END STAGE RENAL DISEASE 90 0.0049
140 CARDIOVASCULAR INSUFFICIENCY 8 0.0049
141 CONSCIOUSNESS FLUCTUATING 5 0.0048
142 RENAL IMPAIRMENT 396 0.0047
143 BILIRUBIN CONJUGATED INCREASED 11 0.0047
144 THALAMUS HAEMORRHAGE 4 0.0046
145 DIABETES INSIPIDUS 11 0.0046
146 BLOOD ALBUMIN DECREASED 36 0.0045
147 RENAL FAILURE 598 0.0045
148 HYPONATRAEMIA 253 0.0045
149 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
150 BLOOD TEST ABNORMAL 63 0.0045
151 BLOOD UREA INCREASED 75 0.0045
152 ASPIRATION 49 0.0045
153 ULCER 71 0.0045
154 RENAL FAILURE ACUTE 184 0.0043
155 SKIN GRAFT 4 0.0043
156 SKIN TEST POSITIVE 4 0.0043
157 ALLODYNIA 5 0.0043
158 BLOOD UREA ABNORMAL 4 0.0043
159 NEUTROPENIC INFECTION 4 0.0042
160 ENTEROBACTER INFECTION 7 0.0042
161 SUPRAVENTRICULAR EXTRASYSTOLES 14 0.0041
162 BRAIN CONTUSION 3 0.0041
163 PUPIL FIXED 7 0.0040
164 HIGH DENSITY LIPOPROTEIN INCREASED 4 0.0040
165 LIVER ABSCESS 13 0.0040
166 GOUT 71 0.0040
167 TRANSPLANT DYSFUNCTION 7 0.0039
168 COAGULATION TEST ABNORMAL 3 0.0039
169 CONJUNCTIVAL OEDEMA 4 0.0039
170 QUADRIPLEGIA 8 0.0039
171 FULL BLOOD COUNT ABNORMAL 40 0.0038
172 PUPILLARY REFLEX IMPAIRED 7 0.0038
173 MICTURITION URGENCY 43 0.0038
174 AREFLEXIA 10 0.0037
175 ORGAN FAILURE 15 0.0037
176 BLOOD SODIUM INCREASED 10 0.0037
177 RHONCHI 5 0.0036
178 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
179 QUADRIPARESIS 6 0.0036
180 PSEUDOMEMBRANOUS COLITIS 8 0.0036
181 BRAIN ABSCESS 9 0.0036
182 NEUTROPHIL COUNT INCREASED 35 0.0034
183 HAEMODYNAMIC INSTABILITY 26 0.0034
184 CARDIAC OUTPUT DECREASED 3 0.0034
185 BLOOD ALBUMIN INCREASED 3 0.0034
186 KLEBSIELLA INFECTION 17 0.0034
187 BLOOD MAGNESIUM DECREASED 29 0.0034
188 ANAEMIA OF CHRONIC DISEASE 3 0.0033
189 CEREBRAL ARTERY EMBOLISM 4 0.0033
190 LYMPHOCYTE COUNT DECREASED 58 0.0033
191 VENTRICULAR ARRHYTHMIA 12 0.0033
192 RALES 19 0.0033
193 EMOTIONAL DISTRESS 393 0.0032
194 TACHYARRHYTHMIA 8 0.0032
195 DELAYED RECOVERY FROM ANAESTHESIA 3 0.0032
196 TUMOUR HAEMORRHAGE 9 0.0032
197 HYPERCOAGULATION 6 0.0031
198 BILE DUCT STONE 10 0.0031
199 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
200 HYDROCEPHALUS 17 0.0031
201 POST PROCEDURAL HAEMATOMA 5 0.0030
202 GAZE PALSY 5 0.0029
203 CENTRAL NERVOUS SYSTEM LYMPHOMA 4 0.0029
204 EXTREMITY NECROSIS 5 0.0029
205 RENAL FAILURE CHRONIC 22 0.0029
206 FANCONI SYNDROME ACQUIRED 5 0.0028
207 HEPARIN-INDUCED THROMBOCYTOPENIA 14 0.0028
208 PRERENAL FAILURE 4 0.0028
209 LUMBAR VERTEBRAL FRACTURE 13 0.0028
210 HYPERPARATHYROIDISM SECONDARY 7 0.0028
211 BLOOD CREATININE INCREASED 181 0.0028
212 VASCULAR INJURY 4 0.0028
213 RENAL INFARCT 4 0.0028
214 PNEUMONIA KLEBSIELLA 5 0.0027
215 KIDNEY TRANSPLANT REJECTION 13 0.0027
216 CORNEAL OEDEMA 6 0.0027
217 HYPERURICAEMIA 11 0.0027
218 PSYCHOLOGICAL TRAUMA 23 0.0027
219 TRANSAMINASES INCREASED 59 0.0027
220 NEPHROGENIC SYSTEMIC FIBROSIS 8 0.0026
221 BLOOD CHOLESTEROL INCREASED 123 0.0026
222 BLOODY DISCHARGE 3 0.0026
223 LUNG INFILTRATION 23 0.0026
224 REACTION TO EXCIPIENT 6 0.0026
225 HYPOALBUMINAEMIA 20 0.0026
226 CYTOMEGALOVIRUS CHORIORETINITIS 5 0.0026
227 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
228 APLASIA 5 0.0026
229 VENOUS THROMBOSIS 10 0.0025
230 HYPERKALAEMIA 89 0.0025
231 URINE OUTPUT DECREASED 22 0.0025
232 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 131 0.0025
233 SEPSIS 276 0.0025
234 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
235 SKIN INDURATION 5 0.0024
236 CEREBRAL HAEMATOMA 8 0.0024
237 NECROSIS 13 0.0023
238 LYMPHOCYTOSIS 5 0.0023
239 VIITH NERVE PARALYSIS 8 0.0023
240 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22 0.0023
241 REACTION TO DRUG EXCIPIENTS 5 0.0023
242 HYPERAMMONAEMIC ENCEPHALOPATHY 4 0.0023
243 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
244 HEMIPLEGIA 19 0.0023
245 ATAXIA 27 0.0023
246 SUBARACHNOID HAEMORRHAGE 23 0.0023
247 CIRCULATORY COLLAPSE 38 0.0022
248 NEPHROPATHY TOXIC 25 0.0022
249 HYPERTRIGLYCERIDAEMIA 13 0.0022
250 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
251 MONOPARESIS 4 0.0022
252 CEREBRAL HAEMORRHAGE 79 0.0022
253 POLYURIA 18 0.0022
254 VENTRICULAR HYPOKINESIA 7 0.0022
255 OTOTOXICITY 4 0.0022
256 NEPHROGENIC ANAEMIA 10 0.0022
257 HYPOPROTEINAEMIA 4 0.0021
258 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
259 OLIGURIA 13 0.0021
260 JOINT INJURY 44 0.0021
261 BRONCHOPNEUMONIA 7 0.0020
262 HYPOKALAEMIA 93 0.0020
263 URINE ANALYSIS ABNORMAL 6 0.0020
264 MIXED LIVER INJURY 6 0.0020
265 VISUAL FIELD DEFECT 14 0.0019
266 RENAL TUBULAR NECROSIS 19 0.0019
267 DIABETES MELLITUS 147 0.0019
268 CORONARY ARTERY DISEASE 58 0.0019
269 BLOOD PHOSPHORUS DECREASED 7 0.0019
270 PSYCHIATRIC SYMPTOM 14 0.0019
271 ELECTROLYTE IMBALANCE 22 0.0019
272 LOW BIRTH WEIGHT BABY 15 0.0019
273 GENERAL PHYSICAL HEALTH DETERIORATION 217 0.0019
274 COMPRESSION FRACTURE 10 0.0019
275 THROMBOSIS 149 0.0019
276 LANGUAGE DISORDER 4 0.0018
277 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
278 CEREBRAL INFARCTION 45 0.0018
279 IRON DEFICIENCY ANAEMIA 17 0.0018
280 ACIDOSIS 14 0.0018
281 DEAFNESS NEUROSENSORY 6 0.0018
282 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
283 VENTRICULAR TACHYCARDIA 30 0.0018
284 NOSOCOMIAL INFECTION 4 0.0018
285 HYPERAMMONAEMIA 9 0.0018
286 SLEEP DISORDER 127 0.0018
287 ANXIETY 511 0.0018
288 CARDIOPULMONARY FAILURE 7 0.0018
289 PULMONARY EMBOLISM 170 0.0018
290 TORSADE DE POINTES 14 0.0018
291 BRONCHIECTASIS 12 0.0018
292 DRY MOUTH 144 0.0018
293 DISABILITY 35 0.0018
294 METASTASES TO MENINGES 4 0.0018
295 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
296 PHLEBITIS 9 0.0018
297 ABDOMINAL DISTENSION 183 0.0018
298 BLOOD CHLORIDE INCREASED 3 0.0017
299 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
300 TUMOUR LYSIS SYNDROME 15 0.0017
301 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
302 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
303 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
304 CARDIOVASCULAR DISORDER 42 0.0017
305 HYPERPYREXIA 7 0.0017
306 INTESTINAL ISCHAEMIA 9 0.0016
307 ISCHAEMIC STROKE 29 0.0016
308 STAPHYLOCOCCAL SEPSIS 8 0.0016
309 TACHYPNOEA 22 0.0016
310 LEUKOENCEPHALOPATHY 6 0.0016
311 ABDOMINAL TENDERNESS 8 0.0016
312 LOWER RESPIRATORY TRACT INFECTION 73 0.0016
313 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
314 HEMIPARESIS 27 0.0016
315 LABYRINTHITIS 4 0.0016
316 HYPOMAGNESAEMIA 22 0.0016
317 CARDIOTOXICITY 14 0.0016
318 ALTERED STATE OF CONSCIOUSNESS 34 0.0016
319 INTENTIONAL PRODUCT MISUSE 136 0.0016
320 METASTASES TO CENTRAL NERVOUS SYSTEM 20 0.0015
321 HAEMODIALYSIS 13 0.0015
322 WHITE BLOOD CELL COUNT INCREASED 59 0.0015
323 SUBDURAL HAEMATOMA 22 0.0015
324 BACTERIAL SEPSIS 5 0.0015
325 COMA 73 0.0015
326 BONE MARROW FAILURE 31 0.0015
327 SWELLING 142 0.0015
328 BACTERAEMIA 18 0.0015
329 RENAL FUNCTION TEST ABNORMAL 7 0.0015
330 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
331 OESOPHAGEAL CANDIDIASIS 6 0.0015
332 ANAEMIA 285 0.0015
333 HYPERLACTACIDAEMIA 4 0.0015
334 DEVICE RELATED SEPSIS 3 0.0015
335 C-REACTIVE PROTEIN INCREASED 54 0.0015
336 HAEMORRHAGE INTRACRANIAL 22 0.0015
337 PERIPHERAL ISCHAEMIA 6 0.0015
338 SUDDEN CARDIAC DEATH 5 0.0015
339 PLEURAL EFFUSION 89 0.0015
340 SUBDURAL HAEMORRHAGE 4 0.0015
341 WOUND COMPLICATION 5 0.0015
342 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
343 RED BLOOD CELL COUNT INCREASED 4 0.0014
344 ASPARTATE AMINOTRANSFERASE INCREASED 77 0.0014
345 HEPATIC FUNCTION ABNORMAL 54 0.0014
346 DRUG INTOLERANCE 138 0.0014
347 ENCEPHALOPATHY 35 0.0014
348 TYPE I HYPERSENSITIVITY 5 0.0014
349 STATUS EPILEPTICUS 16 0.0014
350 PULMONARY HAEMORRHAGE 11 0.0014
351 PNEUMATOSIS INTESTINALIS 4 0.0014
352 NEUROLOGICAL SYMPTOM 8 0.0014
353 DERMATITIS EXFOLIATIVE 7 0.0014
354 HAEMOPTYSIS 39 0.0014
355 PARAPLEGIA 4 0.0014
356 CYTOMEGALOVIRUS INFECTION 23 0.0014
357 HAEMOTHORAX 4 0.0014
358 METABOLIC ACIDOSIS 44 0.0014
359 GASTROINTESTINAL NECROSIS 4 0.0014
360 RESPIRATORY FAILURE 100 0.0014
361 SPUTUM DISCOLOURED 13 0.0014
362 PARONYCHIA 6 0.0014
363 LIVER FUNCTION TEST INCREASED 29 0.0013
364 ATELECTASIS 13 0.0013
365 BACTERIAL TEST POSITIVE 3 0.0013
366 TRANSIENT ISCHAEMIC ATTACK 45 0.0013
367 METABOLIC ENCEPHALOPATHY 4 0.0013
368 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
369 HEPATIC NECROSIS 5 0.0013
370 CENTRAL VENOUS CATHETERISATION 4 0.0013
371 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
372 GRAND MAL CONVULSION 12 0.0013
373 BLOOD CREATININE DECREASED 4 0.0013
374 CYANOSIS 20 0.0013
375 COAGULOPATHY 21 0.0013
376 CEREBRAL ATROPHY 5 0.0013
377 ACUTE PULMONARY OEDEMA 7 0.0012
378 STUPOR 4 0.0012
379 ENTEROCOCCAL INFECTION 6 0.0012
380 ANAPHYLACTIC SHOCK 32 0.0012
381 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
382 UPPER RESPIRATORY TRACT INFECTION 57 0.0012
383 EXTRAVASATION 5 0.0012
384 DRUG-INDUCED LIVER INJURY 38 0.0012
385 APPETITE DISORDER 8 0.0012
386 GASTROINTESTINAL PERFORATION 5 0.0012
387 MENINGITIS 8 0.0012
388 BRAIN INJURY 12 0.0012
389 METASTASES TO SPINE 4 0.0012
390 TONGUE ULCERATION 4 0.0012
391 CARDIAC ARREST 97 0.0012
392 PROCEDURAL COMPLICATION 9 0.0012
393 ALANINE AMINOTRANSFERASE INCREASED 72 0.0012
394 PROTHROMBIN TIME PROLONGED 7 0.0012
395 ENDOCARDITIS 6 0.0012
396 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
397 MALNUTRITION 13 0.0012
398 SOMNOLENCE 233 0.0012
399 LYMPHOEDEMA 8 0.0012
400 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
401 PAPULE 8 0.0011
402 BLOOD POTASSIUM DECREASED 34 0.0011
403 BLOOD CREATINE INCREASED 5 0.0011
404 APHASIA 34 0.0011
405 CONJUNCTIVAL HYPERAEMIA 4 0.0011
406 ILEUS PARALYTIC 5 0.0011
407 PARALYSIS 16 0.0011
408 ANAESTHETIC COMPLICATION 3 0.0011
409 RENAL TRANSPLANT 4 0.0011
410 ABDOMINAL RIGIDITY 3 0.0011
411 HICCUPS 9 0.0011
412 POST PROCEDURAL COMPLICATION 21 0.0011
413 LEUKOPENIA 54 0.0011
414 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
415 PULMONARY MASS 16 0.0011
416 VENTRICULAR EXTRASYSTOLES 11 0.0011
417 THROMBOCYTOPENIA 117 0.0010
418 HYPERGLYCAEMIA 38 0.0010
419 LIVER DISORDER 46 0.0010
420 SINUS BRADYCARDIA 10 0.0010
421 PAIN 634 0.0010
422 PRODUCT LABEL CONFUSION 6 0.0010
423 APNOEA 8 0.0010
424 CONSTIPATION 224 0.0010
425 HAEMORRHAGIC STROKE 8 0.0010
426 CONDITION AGGRAVATED 311 0.0010
427 INTRAOCULAR PRESSURE INCREASED 13 0.0010
428 MYDRIASIS 13 0.0010
429 ODYNOPHAGIA 6 0.0010
430 AZOTAEMIA 4 0.0010
431 LUNG DISORDER 49 0.0010
432 CANDIDIASIS 4 0.0010
433 INTRACRANIAL ANEURYSM 4 0.0010
434 FEBRILE NEUTROPENIA 66 0.0010
435 MUCOSAL INFLAMMATION 26 0.0010
436 NEUTROPHIL COUNT DECREASED 40 0.0010
437 CARDIO-RESPIRATORY ARREST 41 0.0010
438 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
439 ANAPHYLACTOID REACTION 4 0.0010
440 CEREBRAL ISCHAEMIA 5 0.0010
441 PERIPHERAL VASCULAR DISORDER 5 0.0010
442 TEMPERATURE INTOLERANCE 10 0.0010
443 AGRANULOCYTOSIS 18 0.0010
444 HYPOXIA 34 0.0010
445 FOETAL DEATH 5 0.0010
446 DEFORMITY 9 0.0010
447 PULMONARY OEDEMA 43 0.0010
448 INTESTINAL STENOSIS 4 0.0009
449 PANCYTOPENIA 53 0.0009
450 NYSTAGMUS 5 0.0009
451 FEBRILE BONE MARROW APLASIA 4 0.0009
452 POOR PERIPHERAL CIRCULATION 4 0.0009
453 PLATELET COUNT DECREASED 100 0.0009
454 PROCTALGIA 6 0.0009
455 UNRESPONSIVE TO STIMULI 24 0.0009
456 BLOOD BILIRUBIN INCREASED 25 0.0009
457 HEPATITIS ACUTE 6 0.0009
458 ABDOMINAL PAIN 214 0.0009
459 OESOPHAGITIS 10 0.0009
460 SHOCK 21 0.0009
461 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50 0.0009
462 DISORIENTATION 36 0.0009
463 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
464 DEPRESSION 205 0.0009
465 MENTAL STATUS CHANGES 25 0.0009
466 HYPOCALCAEMIA 17 0.0009
467 ANXIETY DISORDER 3 0.0009
468 CARDIAC FAILURE 72 0.0009
469 INTESTINAL PERFORATION 10 0.0009
470 BK VIRUS INFECTION 3 0.0009
471 CLOSTRIDIAL INFECTION 3 0.0009
472 OEDEMA PERIPHERAL 108 0.0009
473 PAPILLOEDEMA 4 0.0009
474 ILEUS 11 0.0009
475 EPILEPSY 27 0.0009
476 PNEUMONIA ASPIRATION 22 0.0009
477 HAEMOGLOBIN DECREASED 90 0.0009
478 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
479 BLOOD CREATININE ABNORMAL 3 0.0009
480 ENCEPHALITIS 6 0.0009
481 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
482 HAEMATOCRIT DECREASED 17 0.0009
483 DIALYSIS 12 0.0008
484 MUSCULOSKELETAL STIFFNESS 74 0.0008
485 RETINAL HAEMORRHAGE 6 0.0008
486 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
487 NEUTROPENIC SEPSIS 6 0.0008
488 LUNG INFECTION 13 0.0008
489 NON-SMALL CELL LUNG CANCER 4 0.0008
490 SUBCUTANEOUS ABSCESS 4 0.0008
491 GASTROINTESTINAL TOXICITY 4 0.0008
492 CAROTID ARTERY OCCLUSION 3 0.0008
493 FACIAL PARALYSIS 7 0.0008
494 HEPATOMEGALY 8 0.0008
495 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
496 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
497 PALLOR 22 0.0008
498 INFLAMMATORY MARKER INCREASED 4 0.0008
499 SEPTIC SHOCK 35 0.0008
500 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
501 HYDRONEPHROSIS 6 0.0008
502 THERAPY NON-RESPONDER 36 0.0008
503 CHRONIC SINUSITIS 3 0.0008
504 HYPOTENSION 160 0.0008
505 RESPIRATORY DISTRESS 22 0.0008
506 HEPATIC FAILURE 24 0.0008
507 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
508 CEREBROVASCULAR ACCIDENT 134 0.0008
509 HYPERTHERMIA 6 0.0008
510 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
511 DRUG RESISTANCE 20 0.0008
512 SINUS TACHYCARDIA 11 0.0008
513 RASH ERYTHEMATOUS 37 0.0008
514 LEUKOCYTOSIS 14 0.0008
515 BLOOD PRESSURE DECREASED 51 0.0008
516 ACUTE KIDNEY INJURY 117 0.0008
517 PARTIAL SEIZURES 4 0.0008
518 BRAIN NEOPLASM 7 0.0008
519 HYPERTHYROIDISM 11 0.0008
520 ORAL CANDIDIASIS 10 0.0008
521 POLYARTHRITIS 4 0.0008
522 BRADYCARDIA 40 0.0008
523 CARDIAC FAILURE ACUTE 5 0.0007
524 ARTERIOSPASM CORONARY 3 0.0007
525 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
526 ANAL ABSCESS 4 0.0007
527 POSTOPERATIVE WOUND INFECTION 5 0.0007
528 CHEILITIS 4 0.0007
529 ESCHERICHIA INFECTION 6 0.0007
530 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
531 NERVOUSNESS 38 0.0007
532 RESPIRATION ABNORMAL 5 0.0007
533 ANAPHYLACTIC REACTION 40 0.0007
534 VOMITING 340 0.0007
535 MYELOSUPPRESSION 26 0.0007
536 PELVIC PAIN 13 0.0007
537 DEVICE RELATED INFECTION 11 0.0007
538 GASTROINTESTINAL DISORDER 64 0.0007
539 LYMPHOPENIA 10 0.0007
540 GRANULOCYTOPENIA 4 0.0007
541 HYPOTONIA 7 0.0007
542 PSEUDOMONAS INFECTION 6 0.0007
543 CYTOKINE RELEASE SYNDROME 14 0.0007
544 PNEUMONITIS 19 0.0007
545 POST PROCEDURAL HAEMORRHAGE 8 0.0007
546 FLUID OVERLOAD 10 0.0007
547 HYPOVOLAEMIA 4 0.0007
548 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
549 PULMONARY FIBROSIS 13 0.0007
550 DRUG ERUPTION 12 0.0007
551 DEEP VEIN THROMBOSIS 44 0.0007
552 CARDIOMYOPATHY 10 0.0007
553 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
554 WRONG DRUG ADMINISTERED 6 0.0007
555 HAEMATURIA 23 0.0007
556 AGITATION 49 0.0007
557 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
558 HYPOAESTHESIA ORAL 10 0.0007
559 ABDOMINAL HERNIA 3 0.0007
560 WHITE BLOOD CELL COUNT DECREASED 71 0.0007
561 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
562 LIVER FUNCTION TEST ABNORMAL 19 0.0007
563 RESPIRATORY DEPRESSION 8 0.0007
564 LIPASE INCREASED 5 0.0007
565 LARYNGEAL OEDEMA 4 0.0006
566 PROCEDURAL PAIN 18 0.0006
567 PYREXIA 224 0.0006
568 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
569 DYSARTHRIA 24 0.0006
570 HYPERTENSION 135 0.0006
571 ATRIAL FIBRILLATION 62 0.0006
572 BLEPHAROSPASM 4 0.0006
573 HEPATOCELLULAR INJURY 9 0.0006
574 COLITIS 24 0.0006
575 DRUG SCREEN POSITIVE 5 0.0006
576 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
577 HEART RATE DECREASED 22 0.0006
578 PARAESTHESIA ORAL 9 0.0006
579 ACUTE RESPIRATORY FAILURE 12 0.0006
580 RHABDOMYOLYSIS 26 0.0006
581 BLOOD CALCIUM DECREASED 7 0.0006
582 INCOHERENT 4 0.0006
583 DECUBITUS ULCER 5 0.0006
584 BRADYPHRENIA 4 0.0006
585 LIVER INJURY 15 0.0006
586 NEUTROPENIA 83 0.0006
587 GASTRITIS 16 0.0006
588 DIABETIC NEUROPATHY 3 0.0006
589 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
590 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
591 EMBOLISM 5 0.0006
592 SKIN MASS 4 0.0006
593 PREMATURE BABY 18 0.0006
594 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
595 JAUNDICE 16 0.0006
596 COLITIS ISCHAEMIC 4 0.0006
597 ARRHYTHMIA 28 0.0006
598 CHILLS 69 0.0006
599 ACUTE HEPATIC FAILURE 8 0.0006
600 BLOOD URINE PRESENT 11 0.0006
601 LARGE INTESTINE PERFORATION 4 0.0006
602 HYPERTRANSAMINASAEMIA 4 0.0006
603 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
604 EXTRASYSTOLES 4 0.0006
605 CYTOPENIA 7 0.0006
606 NEUROTOXICITY 10 0.0006
607 PNEUMOTHORAX 9 0.0006
608 COLD SWEAT 10 0.0006
609 DRUG INTERACTION 90 0.0006
610 PREMATURE DELIVERY 9 0.0006
611 PHARYNGITIS 7 0.0006
612 TACHYCARDIA 50 0.0006
613 LACTIC ACIDOSIS 18 0.0006
614 DEHYDRATION 74 0.0006
615 PRODUCT USE IN UNAPPROVED INDICATION 137 0.0006
616 DERMATITIS BULLOUS 4 0.0006
617 MENTAL DISORDER 24 0.0006
618 EMOTIONAL DISORDER 17 0.0006
619 RESTLESS LEGS SYNDROME 10 0.0005
620 RASH PUSTULAR 4 0.0005
621 GASTROENTERITIS 8 0.0005
622 DYSPHAGIA 52 0.0005
623 HAEMATOMA 14 0.0005
624 NERVE INJURY 6 0.0005
625 URINARY RETENTION 18 0.0005
626 PANCREATITIS ACUTE 12 0.0005
627 FISTULA 6 0.0005
628 ARTERIOSCLEROSIS 5 0.0005
629 ABORTION INDUCED 5 0.0005
630 BLOOD SODIUM DECREASED 10 0.0005
631 MITRAL VALVE INCOMPETENCE 6 0.0005
632 CHOLECYSTITIS ACUTE 3 0.0005
633 CHEST DISCOMFORT 54 0.0005
634 CONVULSION 30 0.0005
635 GLAUCOMA 10 0.0005
636 HAEMOLYSIS 4 0.0005
637 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
638 DYSTONIA 10 0.0005
639 DRUG TOXICITY 7 0.0005
640 THROMBOTIC MICROANGIOPATHY 5 0.0005
641 MENINGIOMA 8 0.0005
642 SPLENOMEGALY 6 0.0005
643 TREMOR 85 0.0005
644 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
645 DISEASE PROGRESSION 60 0.0005
646 RENAL CYST 4 0.0005
647 MYOCLONUS 6 0.0005
648 COORDINATION ABNORMAL 7 0.0005
649 MUSCULAR WEAKNESS 57 0.0005
650 ATRIAL FLUTTER 4 0.0005
651 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
652 PNEUMONIA 162 0.0005
653 DEATH 431 0.0005
654 CHRONIC KIDNEY DISEASE 38 0.0005
655 TRANSPLANT REJECTION 4 0.0005
656 DEAFNESS 13 0.0005
657 RASH MACULO-PAPULAR 11 0.0005
658 MUSCLE DISORDER 4 0.0005
659 SHOCK HAEMORRHAGIC 4 0.0005
660 DYSURIA 18 0.0005
661 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
662 CONJUNCTIVITIS 9 0.0005
663 CHOLANGITIS 3 0.0005
664 HYPERBILIRUBINAEMIA 5 0.0005
665 NERVOUS SYSTEM DISORDER 15 0.0005
666 OXYGEN SATURATION DECREASED 27 0.0005
667 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
668 PETECHIAE 5 0.0005
669 DERMATITIS ALLERGIC 6 0.0005
670 SEIZURE 55 0.0005
671 FACE OEDEMA 8 0.0005
672 INCONTINENCE 5 0.0005
673 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
674 RESPIRATORY ARREST 13 0.0005
675 LETHARGY 27 0.0005
676 SEROTONIN SYNDROME 9 0.0005
677 ANURIA 4 0.0005
678 OFF LABEL USE 406 0.0005
679 CARDIAC MURMUR 4 0.0005
680 OEDEMA 25 0.0005
681 PLATELET COUNT INCREASED 6 0.0005
682 DISCOMFORT 28 0.0005
683 NAUSEA 363 0.0005
684 CHOLELITHIASIS 15 0.0005
685 LOSS OF CONSCIOUSNESS 58 0.0005
686 MUSCULOSKELETAL CHEST PAIN 7 0.0005
687 DENTAL CARIES 5 0.0005
688 RESPIRATORY RATE INCREASED 4 0.0005
689 EJECTION FRACTION DECREASED 7 0.0004
690 STEVENS-JOHNSON SYNDROME 10 0.0004
691 HYPERTENSIVE CRISIS 5 0.0004
692 FEEDING DISORDER 9 0.0004
693 DYSPNOEA 251 0.0004
694 DYSKINESIA 18 0.0004
695 ASTHMA 50 0.0004
696 SPEECH DISORDER 23 0.0004
697 GASTRIC HAEMORRHAGE 5 0.0004
698 HAEMATEMESIS 11 0.0004
699 AUTOIMMUNE HEPATITIS 3 0.0004
700 HEPATITIS 11 0.0004
701 ERYTHEMA MULTIFORME 4 0.0004
702 NEPHROPATHY 4 0.0004
703 MOUTH ULCERATION 9 0.0004
704 FLANK PAIN 4 0.0004
705 STAPHYLOCOCCAL INFECTION 14 0.0004
706 EXPOSURE DURING PREGNANCY 26 0.0004
707 MUSCLE RIGIDITY 5 0.0004
708 MENTAL IMPAIRMENT 10 0.0004
709 ADRENAL INSUFFICIENCY 5 0.0004
710 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
711 ASTHENIA 153 0.0004
712 CARDIOMEGALY 5 0.0004
713 SMALL INTESTINAL OBSTRUCTION 5 0.0004
714 HYPERCALCAEMIA 5 0.0004
715 GENERALISED OEDEMA 5 0.0004
716 RESPIRATORY DISORDER 12 0.0004
717 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
718 SALIVARY HYPERSECRETION 4 0.0004
719 SECRETION DISCHARGE 5 0.0004
720 HYPOTHERMIA 4 0.0004
721 BODY TEMPERATURE INCREASED 8 0.0004
722 MUSCLE TWITCHING 9 0.0004
723 PERICARDIAL EFFUSION 9 0.0004
724 PERITONITIS 8 0.0004
725 THERAPY PARTIAL RESPONDER 6 0.0004
726 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
727 SUDDEN DEATH 4 0.0004
728 DRUG INEFFECTIVE 497 0.0004
729 HEPATIC STEATOSIS 7 0.0004
730 BLOOD PRESSURE FLUCTUATION 9 0.0004
731 EYE HAEMORRHAGE 5 0.0004
732 JOINT RANGE OF MOTION DECREASED 5 0.0004
733 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
734 GASTRIC ULCER 7 0.0004
735 PROTEINURIA 7 0.0004
736 ASPHYXIA 3 0.0004
737 SLEEP APNOEA SYNDROME 7 0.0004
738 METASTASES TO BONE 6 0.0004
739 WOUND INFECTION 4 0.0004
740 MANIA 6 0.0004
741 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
742 GASTROINTESTINAL PAIN 4 0.0004
743 MUSCULOSKELETAL PAIN 19 0.0004
744 MYOCARDIAL INFARCTION 63 0.0004
745 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
746 CANDIDA INFECTION 6 0.0004
747 REBOUND EFFECT 4 0.0004
748 MYOCARDIAL ISCHAEMIA 4 0.0004
749 SCAR 6 0.0004
750 BRONCHOSPASM 5 0.0004
751 RED BLOOD CELL COUNT DECREASED 10 0.0003
752 DIPLOPIA 9 0.0003
753 CAESAREAN SECTION 4 0.0003
754 EOSINOPHILIA 6 0.0003
755 RIB FRACTURE 7 0.0003
756 SYNCOPE 34 0.0003
757 ACUTE MYOCARDIAL INFARCTION 10 0.0003
758 PSYCHOTIC DISORDER 10 0.0003
759 HEPATIC ENZYME INCREASED 23 0.0003
760 WHEEZING 20 0.0003
761 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
762 PULMONARY HYPERTENSION 7 0.0003
763 POLYNEUROPATHY 4 0.0003
764 TOXICITY TO VARIOUS AGENTS 56 0.0003
765 TOOTHACHE 6 0.0003
766 ERYTHEMA 68 0.0003
767 STOMATITIS 20 0.0003
768 NO THERAPEUTIC RESPONSE 4 0.0003
769 RESTLESSNESS 12 0.0003
770 MUSCLE SPASTICITY 4 0.0003
771 RASH 140 0.0003
772 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
773 MELAENA 7 0.0003
774 DELIRIUM 11 0.0003
775 NEOPLASM PROGRESSION 11 0.0003
776 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
777 MUSCULOSKELETAL DISORDER 6 0.0003
778 PRURITUS 120 0.0003
779 INFUSION SITE PAIN 4 0.0003
780 ANOREXIA 4 0.0003
781 INTERSTITIAL LUNG DISEASE 15 0.0003
782 DYSSTASIA 9 0.0003
783 BLOOD POTASSIUM INCREASED 5 0.0003
784 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
785 SKIN DISCOLOURATION 14 0.0003
786 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
787 HEART RATE INCREASED 30 0.0003
788 BLOOD PRESSURE ABNORMAL 6 0.0003
789 DECREASED APPETITE 70 0.0003
790 VISUAL ACUITY REDUCED 10 0.0003
791 CONFUSIONAL STATE 48 0.0003
792 HAEMORRHAGE 31 0.0003
793 RASH PRURITIC 16 0.0003
794 PERIPHERAL COLDNESS 4 0.0003
795 HYPOGLYCAEMIA 14 0.0003
796 INFUSION RELATED REACTION 19 0.0003
797 CARDIAC FAILURE CONGESTIVE 23 0.0003
798 NEUROPATHY PERIPHERAL 27 0.0003
799 BLINDNESS UNILATERAL 4 0.0003
800 EPISTAXIS 21 0.0003
801 MOVEMENT DISORDER 9 0.0003
802 HEADACHE 175 0.0003
803 HALLUCINATION 21 0.0003
804 ABDOMINAL PAIN LOWER 7 0.0003
805 HYPERSENSITIVITY 51 0.0003
806 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
807 LIP SWELLING 9 0.0003
808 RESPIRATORY TRACT INFECTION 7 0.0003
809 ORAL PAIN 6 0.0003
810 BALANCE DISORDER 23 0.0003
811 PHOTOPHOBIA 5 0.0003
812 INTESTINAL OBSTRUCTION 10 0.0003
813 HYPERHIDROSIS 34 0.0003
814 DERMATITIS CONTACT 3 0.0003
815 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003
816 CELLULITIS 13 0.0003
817 URINARY TRACT INFECTION 44 0.0003
818 DELUSION 4 0.0003
819 ACUTE MYELOID LEUKAEMIA 4 0.0003
820 PLASMA CELL MYELOMA 10 0.0003
821 ORAL HERPES 5 0.0003
822 CHOLECYSTITIS 3 0.0003
823 FEELING COLD 7 0.0003
824 DIABETIC KETOACIDOSIS 6 0.0002
825 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
826 THERAPEUTIC RESPONSE DECREASED 15 0.0002
827 MUSCLE TIGHTNESS 4 0.0002
828 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
829 CARDIAC DISORDER 23 0.0002
830 OSTEOPOROSIS 10 0.0002
831 INFECTION 35 0.0002
832 DRUG LEVEL INCREASED 4 0.0002
833 AGGRESSION 12 0.0002
834 TINNITUS 11 0.0002
835 DERMATITIS 5 0.0002
836 URINARY INCONTINENCE 7 0.0002
837 COGNITIVE DISORDER 11 0.0002
838 MEDICATION ERROR 13 0.0002
839 BLOOD GLUCOSE INCREASED 44 0.0002
840 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
841 BLISTER 13 0.0002
842 AMNESIA 15 0.0002
843 PALPITATIONS 27 0.0002
844 PRODUCT PRESCRIBING ISSUE 5 0.0002
845 LOCAL SWELLING 4 0.0002
846 FEELING HOT 14 0.0002
847 LYMPHADENOPATHY 8 0.0002
848 HEAD DISCOMFORT 4 0.0002
849 HEPATOTOXICITY 5 0.0002
850 CHROMATURIA 5 0.0002
851 HYPOAESTHESIA 33 0.0002
852 ADVERSE EVENT 20 0.0002
853 NECK PAIN 12 0.0002
854 RENAL DISORDER 10 0.0002
855 IMPAIRED HEALING 7 0.0002
856 DYSPNOEA EXERTIONAL 8 0.0002
857 BACK PAIN 49 0.0002
858 CHEST PAIN 39 0.0002
859 COUGH 59 0.0002
860 VIRAL INFECTION 7 0.0002
861 PRODUCTIVE COUGH 10 0.0002
862 DIARRHOEA 134 0.0002
863 DYSPHONIA 12 0.0002
864 ABDOMINAL PAIN UPPER 42 0.0002
865 FATIGUE 157 0.0002
866 BLINDNESS 8 0.0002
867 HYPOPHAGIA 5 0.0002
868 DRUG ADMINISTRATION ERROR 6 0.0002
869 ANKLE FRACTURE 3 0.0002
870 INFLAMMATION 10 0.0002
871 SKIN ULCER 5 0.0002
872 POLLAKIURIA 8 0.0002
873 ACCIDENTAL OVERDOSE 7 0.0002
874 BLOOD PRESSURE INCREASED 29 0.0002
875 EYE SWELLING 7 0.0002
876 HYPOTHYROIDISM 6 0.0002
877 IMPAIRED WORK ABILITY 4 0.0002
878 FLUSHING 19 0.0002
879 RECTAL HAEMORRHAGE 8 0.0002
880 POOR QUALITY SLEEP 4 0.0002
881 CATARACT 11 0.0002
882 IRRITABILITY 11 0.0002
883 SKIN LESION 5 0.0002
884 ILL-DEFINED DISORDER 11 0.0002
885 FUNGAL INFECTION 6 0.0002
886 DIZZINESS 86 0.0002
887 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
888 PARAESTHESIA 26 0.0002
889 INSOMNIA 44 0.0002
890 VERTIGO 10 0.0002
891 BLOOD GLUCOSE ABNORMAL 3 0.0002
892 ABASIA 4 0.0002
893 LIMB DISCOMFORT 5 0.0002
894 EXTRAPYRAMIDAL DISORDER 4 0.0002
895 DRY EYE 8 0.0002
896 GASTRIC CANCER 4 0.0002
897 GAIT DISTURBANCE 30 0.0002
898 PRODUCT DOSE OMISSION ISSUE 46 0.0002
899 SKIN EXFOLIATION 13 0.0002
900 SEDATION 4 0.0002
901 UNDERDOSE 11 0.0002
902 ABDOMINAL DISCOMFORT 25 0.0001
903 THROAT TIGHTNESS 4 0.0001
904 OCULAR HYPERAEMIA 7 0.0001
905 MALAISE 64 0.0001
906 VISION BLURRED 20 0.0001
907 INJECTION SITE REACTION 10 0.0001
908 ABNORMAL DREAMS 4 0.0001
909 TREATMENT FAILURE 12 0.0001
910 NIGHTMARE 5 0.0001
911 EYE PAIN 8 0.0001
912 TARDIVE DYSKINESIA 4 0.0001
913 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
914 ANGINA PECTORIS 4 0.0001
915 HYPOACUSIS 6 0.0001
916 PAIN IN EXTREMITY 41 0.0001
917 FALL 46 0.0001
918 DRUG EFFECT INCOMPLETE 5 0.0001
919 URTICARIA 23 0.0001
920 MUSCLE SPASMS 25 0.0001
921 NASAL CONGESTION 8 0.0001
922 BRONCHITIS 10 0.0001
923 PANCREATITIS 7 0.0001
924 DYSPEPSIA 13 0.0001
925 OVERDOSE 28 0.0001
926 TREATMENT NONCOMPLIANCE 7 0.0001
927 ABNORMAL BEHAVIOUR 5 0.0001
928 DISEASE RECURRENCE 6 0.0001
929 MOBILITY DECREASED 9 0.0001
930 NIGHT SWEATS 4 0.0001
931 WEIGHT DECREASED 34 0.0001
932 VISUAL IMPAIRMENT 15 0.0001
933 SKIN DISORDER 4 0.0001
934 BONE PAIN 7 0.0001
935 WITHDRAWAL SYNDROME 5 0.0001
936 FLUID RETENTION 6 0.0001
937 OSTEOARTHRITIS 5 0.0001
938 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
939 ANGIOEDEMA 5 0.0001
940 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
941 DISTURBANCE IN ATTENTION 6 0.0001
942 INFLUENZA LIKE ILLNESS 9 0.0001
943 OROPHARYNGEAL PAIN 10 0.0001
944 SWELLING FACE 7 0.0001
945 DEMENTIA 3 0.0001
946 CONTUSION 10 0.0001
947 ALOPECIA 20 0.0001
948 ARTHRITIS 8 0.0001
949 LUNG NEOPLASM MALIGNANT 4 0.0001
950 DEPRESSED MOOD 5 0.0001
951 DYSGEUSIA 7 0.0001
952 NO ADVERSE EVENT 17 0.0001
953 INTENTIONAL OVERDOSE 6 0.0001
954 DRUG EFFECT DECREASED 5 0.0001
955 VAGINAL HAEMORRHAGE 4 0.0001
956 HAEMATOCHEZIA 5 0.0001
957 ANGER 3 0.0001
958 INJECTION SITE ERYTHEMA 11 0.0001
959 FLATULENCE 5 0.0001
960 MEMORY IMPAIRMENT 12 0.0001
961 NEPHROLITHIASIS 4 0.0001
962 BLOOD GLUCOSE DECREASED 4 0.0001
963 SUICIDE ATTEMPT 5 0.0001
964 DRY SKIN 11 0.0001
965 ARTHRALGIA 34 0.0001
966 PRODUCT USE ISSUE 15 0.0001
967 ECZEMA 4 0.0001
968 ABORTION SPONTANEOUS 3 0.0001
969 WEIGHT INCREASED 16 0.0001
970 BURNING SENSATION 5 0.0001
971 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
972 ACNE 5 0.0001
973 SUICIDAL IDEATION 6 0.0001
974 MYALGIA 11 0.0001
975 RHINORRHOEA 4 0.0001
976 RHEUMATOID ARTHRITIS 7 0.0001
977 DRUG ABUSE 5 0.0001
978 NEOPLASM MALIGNANT 4 0.0001
979 NASOPHARYNGITIS 11 0.0001
980 FEELING ABNORMAL 14 0.0001
981 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
982 COVID-19 10 0.0001
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
984 ADVERSE DRUG REACTION 5 0.0001
985 DEPENDENCE 3 0.0001
986 ARTHROPATHY 3 0.0001
987 INCORRECT DOSE ADMINISTERED 12 0.0001
988 PERIPHERAL SWELLING 8 0.0001
989 SINUSITIS 5 0.0000
990 INJECTION SITE PAIN 12 0.0000
991 PSORIASIS 5 0.0000
992 PRODUCT QUALITY ISSUE 5 0.0000
993 INFLUENZA 4 0.0000
994 DRUG DOSE OMISSION 5 0.0000
995 HOSPITALISATION 4 0.0000